Aris Angelis

@Aris_Angelis

Evaluation of new medical technologies, drug R&D enthusiast. Research Officer & PhD candidate at LSE Health, ICL/ KCL/ LSE graduate. Views are my own.

London, England
Joined June 2015

@Aris_Angelis is blocked

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @Aris_Angelis.

  1. Pinned Tweet

    Following your readers' request, an updated version including marketing/selling related expenses

  2. has provided a worrisome model for the next generation of molecularly targeted therapies

  3. Open access to is good for public health. Share your thoughts!

  4. Who makes more new medicines - big vs small co's? VC-backed companies? Exploring the Origination Of New Medicines

  5. A look at drug industry productivity - what's changed and what hasn't:

  6. Clinton and Trump reflect “deep underlying political forces and historical experiences”

  7. Could anyone else live to be 122?

  8. How to balance speed of new drug approvals w pt safety & use surrogate endpoints

  9. Nobel Prize in Physiology or Medicine goes to Japanese scientist Yoshinori Ohsumi for his work on autophagy

  10. requires more comprehensive and flexible value assessment in a structured and transparent way

  11. Can we talk about innovation in healthcare disregarding medicinal products for stem cell therapies?

  12. Secrecy n black boxes need to be replaced with transparency n public accountability

    • @broadinstitute

      A unique, collaborative community pioneering a new model of biomedical science

    • @CMO_England

      Official Twitter page of the Office of the Chief Medical Officer, Professor Dame Sally C Davies. Most tweets by officials. Direct quotes signed 'CMO'.

  13. Opening plenary session by Helmut Brand

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·